Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 2,820.00
+195.00 (7.43%)
At close: Aug 14, 2025, 3:30 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 233.56 billion as of August 15, 2025. Its market cap has increased by 330.83% in one year.
Market Cap
233.56B
Enterprise Value
219.25B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,820.00
Market Cap Chart
Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 233.56B, a decrease of -22.19%. That is a compound annual growth rate of -4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 233.56B | 23.55% |
| Dec 30, 2024 | 189.04B | 158.57% |
| Dec 28, 2023 | 73.11B | -68.32% |
| Dec 29, 2022 | 230.80B | -17.53% |
| Dec 30, 2021 | 279.85B | 0.27% |
| Dec 30, 2020 | 279.09B | -12.04% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 470.21T |
| SK hynix | 191.92T |
| LG Energy Solution | 91.14T |
| Samsung Biologics | 74.02T |
| Hyundai Motor Company | 47.20T |
| Hanwha Aerospace | 45.17T |
| Doosan Enerbility | 42.59T |
| KB Financial Group | 41.73T |